MedTrace Logo

Study Assessing the Effects on Endometrium and Breast of Isoflavone in Post Menopausal Women

NCT00235924 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2005-12-08

No results posted yet for this study

Summary

The main objective of this study is to determine the effects on the endometrium and breast of 70 mg daily dose of isoflavones.

Conditions

  • Postmenopause

Interventions

DRUG

soy isoflavone

Sponsors & Collaborators

  • Laboratoires Arkopharma

    lead INDUSTRY

Principal Investigators

  • Pierre MARES, Professor · Hospital of Caremeau, Nîmes, FRANCE

  • Santiago PALACIOS, Professor · Instituto Palacios, Madrid, SPAIN

  • Bruno PORNEL, Doctor · Brussels Menopause Center, Bruxelles, BELGIUM

  • John EDEN, Professor · Sydney Menopause Center, Sydney, AUSTRALIA

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00235924 on ClinicalTrials.gov